TY - JOUR T1 - Effects of perindopril on soluble intercellular adhesion molecule-1 in patients with congestive heart failure JF - Heart JO - Heart SP - 417 LP - 417 DO - 10.1136/heart.88.4.417 VL - 88 IS - 4 AU - X-M Wang AU - Y Li AU - H-F Li AU - F Liu AU - G-L Jia Y1 - 2002/10/01 UR - http://heart.bmj.com/content/88/4/417.abstract N2 - There is increasing evidence that pro-inflammatory molecules play an important role in the ventricular remodelling of congestive heart failure (CHF).1 Among these molecules, intercellular adhesion molecule-1 (ICAM-1) is a key mediator for the necrosis of cardiac muscle. This study compares, for the first time, the effects of the angiotensin converting enzyme (ACE) inhibitor perindopril and conventional treatment on plasma soluble ICAM-1 (sICAM-1). Eighty four patients with CHF presenting to the department of cardiology and department of geriatrics at Xijing Hospital between December 2000 and March 2001 were recruited. Before treatment, the patients were informed about the advantages and disadvantages of perindopril treatment and treated according to their own choice. They were then divided into two treatment groups. The perindopril group comprised 42 patients (32 men, 10 women, mean (SD) age 63.2 (6.2) years, range 37–84 years), with New York Heart Association (NYHA) functional class II (7 patients), III (22 patients), and IV (13 patients) heart failure. The conventional treatment group also comprised 42 patients (25 men, 17 women, mean age 56.5 (7. 6), range 42–79 years) with NYHA functional class II (9 patients), III (19 patients), and IV (14 patients) heart failure. The causes of CHF included rheumatic heart disease (29 patients), coronary heart disease (23 patients), and dilated cardiomyopathy (11 patients). The control group comprised 30 healthy individuals … ER -